Antioxidant treatments for schizophrenia
Version 2 2024-06-03, 19:25
Version 1 2016-05-11, 15:58
journal contribution
posted on 2024-06-03, 19:25 authored by PVS Magalhães, Olivia DeanOlivia Dean, AC Andreazza, Michael BerkMichael Berk, F KapczinskiAntioxidant treatments for schizophrenia
History
Journal
Cochrane Database of Systematic ReviewsVolume
2016Article number
ARTN CD008919Location
EnglandISSN
1469-493XeISSN
1469-493XLanguage
EnglishPublication classification
C Journal article, C1 Refereed article in a scholarly journalCopyright notice
2016, WileyIssue
2Publisher
WILEYUsage metrics
Categories
No categories selectedKeywords
Science & TechnologyLife Sciences & BiomedicineMedicine, General & InternalGeneral & Internal MedicineVITAMIN-E TREATMENTPLACEBO-CONTROLLED TRIALN-ACETYL CYSTEINEDOUBLE-BLINDTARDIVE-DYSKINESIAGINKGO-BILOBANEGATIVE SYMPTOMSOXIDATIVE STRESSSUPEROXIDE-DISMUTASEGLOBAL ASSESSMENT111799 Public Health and Health Services not elsewhere classified920499 Public Health (excl. Specific Population Health) not elsewhere classifiedSchool of MedicineInnovation in Mental and Physical Health and Clinical TreatmentFaculty of Health110319 Psychiatry (incl Psychotherapy)920410 Mental Health3202 Clinical sciences4203 Health services and systems420313 Mental health services200409 Mental health
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC